Table 2 Comparison of qualitative variables between malignant and benign groups.
Variable | Status | Benign (%) | Malignant (%) | Total (%) | p-value |
|---|---|---|---|---|---|
Predominant high signal on T2* | No | 59 (70.2%) | 0 (0%) | 59 | 0.001+ |
Yes | 25 (29.8%) | 21 (100%) | 46 | ||
Total | 84 (0 missing) | 21 (0 missing) | 105 | ||
Hyper signal areas on T1 | No | 78 (94%) | 18 (85.7%) | 96 | 0.20+ |
Yes | 5 (6%) | 3 (14.3%) | 8 | ||
Total | 83 (1 missing) | 21 (0 missing) | 104 | ||
Central Necrosis* | No | 80 (95.2%) | 11 (52.4%) | 91 | 0.001+ |
Yes | 4 (4.8%) | 10 (47.6%) | 14 | ||
Total | 84 (0 missing) | 21 (0 missing) | 105 | ||
Restriction* | Negative | 76 (95%) | 0 (0%) | 76 | 0.001+ |
Positive | 4 (5%) | 21 (100%) | 25 | ||
Total | 80 (4 missing) | 21 (0 missing) | 101 | ||
MRS Choline peak* | Negative | 45 (92%) | 4 (30%) | 49 | 0.001+ |
Positive | 4 (8%) | 9 (70%) | 13 | ||
Total | 49 (35 missing) | 13 (8 missing) | 62 | ||
MRS Lipid peak* | Negative | 48 (96%) | 5 (39%) | 53 | 0.001+ |
Positive | 2 (4%) | 8 (61%) | 10 | ||
Total | 50 (34 missing) | 13 (8 missing) | 63 |
